---
ID: 3739
post_title: 'HK regulator says Alibaba broke takeover rules due to &#039;special deal&#039;'
author: Staff Writer
post_date: 2016-05-18 11:04:13
post_excerpt: ""
layout: post
permalink: >
  https://www.whenitson.com/hk-regulator-says-alibaba-broke-takeover-rules-due-to-special-deal/
published: true
original_cats:
  - technologyNews
original_title:
  - 'HK regulator says Alibaba broke takeover rules due to &#039;special deal&#039;'
original_link:
  - >
    http://feeds.reuters.com/~r/reuters/technologyNews/~3/_sbRGnTGh3s/us-alibaba-ali-health-sfc-idUSKCN0Y9192
canonical_url:
  - >
    http://feeds.reuters.com/~r/reuters/technologyNews/~3/_sbRGnTGh3s/us-alibaba-ali-health-sfc-idUSKCN0Y9192
---
 [ad_1]
<br><div id="articleText">
<span id="midArticle_start"/>

<span class="focusParagraph" readability="5"><p><span class="articleLocation">HONG KONG</span> Hong Kong's securities regulator said on Wednesday that Chinese e-commerce giant Alibaba Group Holding Ltd (<span id="symbol_BABA.N_0">BABA.N</span>)  breached takeover rules in the purchase of a healthcare firm in 2014 because it also bought a company owned by the brother of the healthcare firm's vice chairman at "favourable terms".</p></span><span id="midArticle_0"/><p>Alibaba agreed to buy CITIC 21CN, now known as Alibaba Health Information Technology Ltd (<span id="symbol_0241.HK_1">0241.HK</span>), for $170 million at the time.</p><span id="midArticle_1"/><p>During the acquisition process, Alibaba also agreed to buy Hebei Huiyan Medical Technology Co from Chen Wen Xin, who was also a shareholder of CITIC 21CN and is the younger brother of the company's vice chairman, Chen Xiao Ying. </p><span id="midArticle_2"/>
        
        <span class="first-article-divide"/><p>Hong Kong's Takeovers and Mergers Panel, part of the Securities and Futures Commission (SFC), ruled that Alibaba's purchase of Hebei Huiyan "constituted a special deal with favourable conditions which were not extended to all shareholders was a clear breach of the Takeovers Code," according to the decision published on Wednesday.</p><span id="midArticle_3"/><p>Alibaba has already said it will appeal the panel's decision, which was unveiled last month without the full details.</p><span id="midArticle_4"/>
        
        <span class="second-article-divide"/><p>The company didn't immediately reply to a Reuters request for comment on the SFC's published decision.</p><span id="midArticle_5"/>
        
        <span class="third-article-divide"/><span id="midArticle_6"/><p> (Reporting by Elzio Barreto; Additional reporting by Paul Carsten in Beijing; Editing by Kim Coghill)</p><span id="midArticle_7"/></div>
<br>[ad_2]
<br><a href="http://feeds.reuters.com/~r/reuters/technologyNews/~3/_sbRGnTGh3s/us-alibaba-ali-health-sfc-idUSKCN0Y9192">Source </a>